Fondazione Telethon and Orphan Therapeutics Accelerator Sign Memorandum of Understanding to Pioneer Nonprofit Commercial Access Model for Ultra-Rare Disease Gene Therapy in the US

Previous
Previous

ASGCT and Orphan Therapeutics Accelerator Launch CGTxchange - A First-of-Its-Kind Marketplace to Reactivate Promising Shelved Cell and Gene Therapy Programs

Next
Next

Orphan Therapeutics Accelerator Launches Orphan Therapies, a Non-Profit Biotech Dedicated to Commercializing Ultra-Rare Disease Treatments